This inventor holds 3 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Auspex Pharmaceuticals, Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Soumen Pattanayek: Innovator in Osmotic Dosage Forms
Introduction
Soumen Pattanayek is a notable inventor based in Weston, FL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of osmotic dosage forms.
Latest Patents
One of his key patents is titled "Osmotic dosage forms comprising deutetrabenazine and methods of use thereof." This patent describes osmotic dosage forms that contain deutetrabenazine, which are intended for the treatment of hyperkinetic movement disorders. When administered orally on a once-daily basis, these dosage forms provide a favorable pharmacokinetic profile for the active agent, indicating treatment efficacy over an extended period of time.
Career Highlights
Soumen Pattanayek is currently associated with Auspex Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing drug delivery systems to improve patient outcomes.
Collaborations
He collaborates with talented professionals in his field, including Parag Shah and Mayank Joshi, contributing to a dynamic and innovative work environment.
Conclusion
Soumen Pattanayek's contributions to osmotic dosage forms and his ongoing work at Auspex Pharmaceuticals, Inc. highlight his commitment to advancing pharmaceutical innovations. His patent on deutetrabenazine showcases the potential for improved treatment options in movement disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile